• Mashup Score: 2

    AcneAnti-AgingAtopic Dermatitis BPDCNHair & ScalpNP and PAPsoriasis Rare DiseaseRosaceaSkin Cancer (Melanoma)Skin Cancer (Non-Melanoma)VitiligoWound CareDevice TechnologyDrug WatchLegalLifestyleNP and PAPractice Management 2 Minute DrillAround the PracticeBetween The LinesCase Based Peer PerspectiveDermviewDermview: VitiligoEditorial Board NewsExpert InterviewsFrontline ForumInside the…

    Tweet Tweets with this article
    • The March issue of Dermatology Times is live! Discover more about #nutrition and #AtopicDermatitis, scoring #alopecia, and #biologics. Download now or follow along as more content is posted throughout the month. https://t.co/Woda6SgK1D https://t.co/2XqQ4F6M6c

  • Mashup Score: 0

    DENVER — Early data suggest combination therapy with biologics or advanced small-molecules may be safe and effective in patients with inflammatory bowel disease, according to a presenter at the Crohn’s and Colitis Congress.“We have all these different mechanisms of action right now — in newer development are some of the oral and p-19 [inhibitors],” Edward V. Loftus

    Tweet Tweets with this article
    • Early data suggest combination therapy with #biologics or advanced small-molecules may be safe and effective in patients with #IBD, according to a presenter at #CCCongress23; @EdwardLoftus2 said, “we have all these different targets: Why not combine them?” https://t.co/RqnadklkZq